GENESYSTEM
LIVE

Serial Number

79328112

Owner

Genesystem Co., Ltd.

Attorney

Michael T. Smith

Filing Date

Oct 25, 2021

Add to watchlist:

No watchlists yet
View on USPTO

GENESYSTEM Trademark

Serial Number: 79328112 • Registration: 7510037

GENESYSTEM is a trademark filed by Genesystem Co., Ltd. on October 25, 2021. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

Genesystem Co., Ltd. (2 trademarks)

200-9, Techno 2-ro, Yuseong-gu

Entity Type: 03

Trademark Details

Filing Date

October 25, 2021

Registration Date

September 24, 2024

Published for Opposition

July 9, 2024

Goods & Services

Reagent paper for veterinary purposes; reagents for use in veterinary genetic testing; veterinary diagnostic reagents; diagnostic agents for pharmaceutical use; diagnostic test reagents for medical or veterinary purposes; biological and chemical reagents for medical or veterinary purposes; reagents and media for medical and veterinary diagnostic purposes; diagnostic chemical reagents for medical use; diagnostic reagents for medical or veterinary purposes; immunoassay reagents for medical use; biological reagents for medical purposes; reagents for medical use; reagent paper for medical purposes; reagents for use in medical genetic testing; medical diagnostic reagents; chemical test reagents for medical use; clinical diagnostic reagents for medical use; diagnostic biomarker reagents for medical purposes

Diagnostic reagents for scientific or research use; reagents for scientific or medical research use; reagents for analyzing proteins for scientific or laboratory purposes; reagents for nucleic acid amplifications for scientific or laboratory purposes; reagents for extracting proteins for scientific or laboratory purposes; reagents for analyzing nucleic acid for scientific or laboratory purposes; in vitro diagnostic reagents for scientific purposes; antibody reagents for scientific purposes; reagents for scientific purposes for use in nucleic acid isolation and purification; reagents for nucleic acid amplification other than for medical purposes; biological preparations for use in biotechnology other than medical use; reagents for cell straining other than medical use; reagents for cell transformation other than medical use; reagents for research purposes; chemical reagents for use in genetic research; chemical reagents for genetic identity testing; diagnostic reagents, other than for medical or veterinary purposes; reagents for use in scientific apparatus for chemical or biological analysis; protein synthesis chemical reagent other than for medical purposes; chemical reagent for extracting nucleic acid other than for medical purposes

genetic testing apparatus for medical purposes; genetic testing apparatus for medical purposes for gene verification; miniaturized sensors for use in gene analysis and diagnosis for medical purposes; real-time gene amplification equipment for medical use; medical genetic fragment analyzers; genetic testing apparatus for medical purposes; medical genetic analyzer; biopsy forceps; diagnostic testing apparatus for medical purposes for testing whole blood, serum, sputum, urine, fecal feces, tissue, cells, DNA and RNA; apparatus for taking blood samples; apparatus for DNA and RNA testing for medical purposes; DNA and RNA extraction and purification apparatus for medical purposes; medical immunoassay apparatus for testing whole blood, serum, sputum, urine, fecal feces, tissue, cells, DNA and RNA; medical instruments for application in human bodies, namely, diagnostic kit comprised of medical diagnostic apparatus for testing for viruses, bacteria, fungi, parasite, rickettsia and protista being a pathogen ; medical apparatus for clinical diagnosis for testing whole blood, serum, sputum, urine, fecal feces, tissue, cells, DNA and RNA; clinical diagnostic kit comprised of test chips for the analysis of body fluids, premix mix, nuclease free water, blood sampling tubes and sealing tapes for testing whole blood, serum, sputum, urine, fecal feces, tissue, cells, DNA and RNA; patient medical monitoring instruments for monitoring DNA amplification results; medical instruments, namely, PCR system comprised of, multiplex biochips for analysis of bodily fluids, diagnostic kit comprised of medical diagnostic apparatus for testing for viruses, bacteria, fungi, parasite, rickettsia and protista being a pathogen, PCR reagents; immunoadsorption columns for medical diagnostic use

Research and development of DNA chips; DNA screening for scientific research purposes; DNA analysis for scientific research purposes; DNA sequence analysis for scientific research purposes; DNA testing services to determine paternity being laboratory services; providing information relating to scientific analysis of the genetic information via online networks; biological information check being genetic testing for scientific research purposes; biological information check being genetic testing for medical research purposes; research in the field of gene analysis; genetic fingerprinting being DNA analysis services for scientific research purposes; laboratory research in the field of gene expression; scientific research in the fields of biomedicine; consultancy in analysis of biology sequence processing for medical research purposes; biological research; biochemical research; biotechnological research relating to industry; development of biotechnology; research and development of technology for biotechnology; multiple nucleic acid analysis for scientific research purposes; protein analysis being scientific laboratory services

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB
Mar 22, 2025 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Feb 27, 2025 FICS
FINAL DISPOSITION PROCESSED
Feb 26, 2025 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Dec 24, 2024 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Sep 24, 2024 NRCC
REGISTERED-PRINCIPAL REGISTER
Sep 24, 2024 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jul 9, 2024 NPUB
PUBLISHED FOR OPPOSITION
Jul 9, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jun 19, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 5, 2024 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 4, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 4, 2024 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Jun 4, 2024 ERFR
NOTIFICATION OF FINAL REFUSAL EMAILED
Feb 6, 2024 GNFN
FINAL REFUSAL E-MAILED
Feb 6, 2024 GNFR
FINAL REFUSAL WRITTEN
Feb 6, 2024 CNFR
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
May 30, 2023 OPNX
LIMITATION FROM THE IB - REQUEST EXAM REVIEW
May 11, 2023 LIME
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
May 10, 2023 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
May 10, 2023 OPNR
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 20, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 20, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 20, 2023 TROA
LIMITATION OF GOODS RECEIVED FROM IB
Mar 4, 2023 LIMG
REFUSAL PROCESSED BY IB
Oct 10, 2022 RFNP
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Sep 21, 2022 RFCS
REFUSAL PROCESSED BY MPU
Sep 20, 2022 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Aug 5, 2022 RFCR
NON-FINAL ACTION WRITTEN
Aug 4, 2022 CNRT
ASSIGNED TO EXAMINER
Aug 2, 2022 DOCK
APPLICATION FILING RECEIPT MAILED
Dec 14, 2021 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 10, 2021 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Dec 9, 2021 REPR